Cytori Therapeutics reported $5.12M in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Baxter International BAX:US $ 3395M 149M
Cytori Therapeutics CYTX:US $ 5.12M 1.19M
Dr.Reddys Laboratories DRRD:IN 45.94B 7.23B
Genocea Biosciences GNCA:US $ 16.04M 2.63M
Haemonetics HAE:US $ 230.69M 15.11M
Infinity Pharmaceuticals INFI:US $ 12.7M 355K
Merrimack Pharmaceuticals MACK:US $ 486K 354K
Mirati Therapeutics MRTX:US $ 182.57M 2.36M
Northwest Biotherapeutics NWBO:US 21.69M 9.41M
Starpharma Holdings Ltd SPL:AU 10.82M 330K
Sun Pharmaceuticals SUNP:IN IR 86110.4M 31485.9M
Teva Pharmaceutical TEVA:IT 4.74B 361M